Top Markets
#1 Akedo Akedo +82.13%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.35%
#4 Cross Cross +45.57%
#5 Black Phoenix Black Phoenix +34.20%
#6 Velvet Velvet +32.22%
#7 OVERTAKE OVERTAKE +19.61%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.80%
#9 Cap Cap +15.18%
#10 QANplatform QANplatform +14.83%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Solarvest BioEnergy Inc. Solarvest BioEnergy Inc.

Solarvest BioEnergy Inc.

SVS
Rank in Stocks #38864
Solarvest BioEnergy Inc. specializes in harnessing algal-based production... Solarvest BioEnergy Inc. specializes in harnessing algal-based production systems to develop natural, environmentally friendly commercial products for both Canadian and international markets. The company's offerings span human nutrition, including omega-3; a clean energy solution for continuous hydrogen production; and pharmaceutical components for human health. These pharmaceutical applications specifically include cannabinoids derived from algae and bone morphogenetic protein for treating bone fractures. Solarvest BioEnergy Inc. also has a collaborative research and development agreement with FSD Pharma Inc. to create pharmaceutical-grade cannabinoids using algae. Established in 2005, the company is headquartered in Vancouver, Canada.
Share Price
$0.01823546
Last synced: 2023-10-03
Market Cap
$767.12K
Change (1 day)
-0.22%
Change (1 year)
0.00%
Country
CA
Trade Solarvest BioEnergy Inc. (SVS)

Category

Healthcare
Revenue for Solarvest BioEnergy Inc. (SVS)
Revenue in Aug 2026 TTM: 0
According to Solarvest BioEnergy Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Solarvest BioEnergy Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE